跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Janumet - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Janumet
Approved
STANDARD
Janumet
Patheon Puerto Rico, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
effd753cd1f4812f
Company
Patheon Puerto Rico, Inc.
Type
Standard
Approval Details
Approval Id
effd753cd1f4812f
Drug Approval Philippines Name
Janumet
Product Name
Janumet
Registration Number
DRP-4011
Brand Name
Janumet
Generic Name
Sitagliptin (as Monohydrate Phosphate) + Metformin Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
50mg/850mg
Manufacturer
Patheon Puerto Rico, Inc.
Importer
Merck Sharp & Dogme (I.A.) LLC
Distributor
Merck Sharp & Dogme (I.A.) LLC
Company Detail Path
/organization/patheon-puerto-rico-inc
Issuance Date
29 February 2024
Expiry Date
14 March 2029
Pharmacologic Category
Antidiabetic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
effd753cd1f4812f
Type
Standard
Back to Philippines FDA Approvals